Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-11

Clinical Trial Update: Demonstrate Efficacy and Safety of Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial in metastatic breast cancer conducted by Celltrion has completed and posted its results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Celltrion | Conditions: Metastatic Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2025-02-11